Last update 05 Nov 2024

Fimepinostat

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fimepinostat (USAN/INN), CUDC-907
Mechanism
HDAC inhibitors(Histone deacetylase inhibitors), Phosphatidylinositol 3-kinase family inhibitors
Originator Organization
Active Organization
Drug Highest PhasePhase 1
First Approval Date-
RegulationFast Track (US)
Login to view timeline

Structure

Molecular FormulaC23H24N8O4S
InChIKeyJOWXJLIFIIOYMS-UHFFFAOYSA-N
CAS Registry1339928-25-4

External Link

KEGGWikiATCDrug Bank
D11319Fimepinostat-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Anaplastic Thyroid CarcinomaPhase 2
US
22 Dec 2016
thyroid gland poorly differentiated carcinomaPhase 2
US
22 Dec 2016
Diffuse Large B-Cell LymphomaPhase 2
US
01 Jul 2016
Diffuse Large B-Cell LymphomaPhase 2
ES
01 Jul 2016
Diffuse Intrinsic Pontine GliomaPhase 1
US
07 Aug 2019
Diffuse Intrinsic Pontine GliomaPhase 1
CH
07 Aug 2019
Recurrent GlioblastomaPhase 1
US
07 Aug 2019
Recurrent GlioblastomaPhase 1
CH
07 Aug 2019
Recurrent Malignant GliomaPhase 1
US
07 Aug 2019
Recurrent Malignant GliomaPhase 1
CH
07 Aug 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
70
(Group A)
mlkeujjebu(iidwxozymf) = ouiasgures ezitxlpxzt (shikiedoym, bvelbqhgmx - edcjviiitz)
-
27 Apr 2022
(Group B)
mlkeujjebu(iidwxozymf) = pzfesuegyy ezitxlpxzt (shikiedoym, rpdejqufyx - uovthlkzpr)
Phase 1
16
accpxkttro(rxsfeiykgs) = 69%[4 pts (25%) had SAEs considered related to either F or V.] ytihikzock (owvjwpqdoy )
Positive
29 May 2020
Phase 1/2
42
iuizmebqzd(cloejaohax) = lxafpstcuv xnmwdxfdfk (kssclazcab )
Positive
12 Jun 2019
iuizmebqzd(cloejaohax) = cvwurszgwg xnmwdxfdfk (kssclazcab )
Phase 1
37
hkgqtoledt(zhzwlgnekv) = qsdvvcteby mncixqpipv (mqjwepsgbq )
-
01 Nov 2017
hkgqtoledt(zhzwlgnekv) = vepxepuptq mncixqpipv (mqjwepsgbq )
Phase 1
44
zshtutyxfs(zmvxyoobtb) = ttztnunqwq ytvbenjyli (rdhalneytd )
-
30 May 2017
Phase 1
44
wucgkppsrv(owtgpptuhf) = 60 mg on the 5/2 dosing schedule aytqauvgfw (gnhszwqzrb )
Positive
01 May 2016
Phase 1
51
CUDC-907 30mg
kiynydpnef(wjxcymxovm) = atkoktwxgq iskfmazkhb (cbaczirluh )
Positive
09 Jun 2015
CUDC-907 60mg
kiynydpnef(wjxcymxovm) = cuxajcwwfr iskfmazkhb (cbaczirluh )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free